BackEver Supreme Bio Technology , Ltd Overview

Ever Supreme Bio Technology , Ltd Inventory

Ever Supreme Bio Technology , Ltd's inventory is $72M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$72.42M
↓ 31.15% YoYΔ $-32.77M vs prior year quarter

Peer trimmed avg / median

Loading

Ever Supreme Bio Technology , Ltd Inventory History

Loading

Ever Supreme Bio Technology , Ltd vs. peers: Inventory Comparison

Loading

Ever Supreme Bio Technology , Ltd Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ever Supreme Bio Technology , Ltd (6712.TWO) FAQ

Ever Supreme Bio Technology , Ltd's inventory stands at $72M as of June 2026. That compares with $110M in the prior-year period — down 31.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ever Supreme Bio Technology , Ltd reported $72M in inventory versus $110M a year earlier — a 31.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $110M in the prior-year period — down 31.2% year over year. Sustained growth in inventory can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Ever Supreme Bio Technology , Ltd's inventory evolved across reporting periods, while the comparison chart places 6712.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, inventory is commonly used to spot outliers. Ever Supreme Bio Technology , Ltd's reading of $72M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.